Finding 395702 (2023-001)

Material Weakness
Requirement
B
Questioned Costs
-
Year
2023
Accepted
2024-05-02

AI Summary

  • Answer: The Organization will assign staff to monitor subaward recipients more frequently.
  • Trend: This action aims to prevent budget overruns for patient accrual in clinical trials.
  • List: Follow up on personnel assignments and monitor compliance with budget limits quarterly.

Finding Text

Planned corrective action: The Organization will establish the appropriate personnel to ensure that subaward recipients are monitored on a more frequent basis to ensure it does not exceed the established budget for patients accruing to clinical trials for the federal award during that quarter.

Corrective Action Plan

The Organization will establish the appropriate personnel to ensure that subaward recipients are monitored on a more frequent basis to ensure it does not exceed the established budget for patients accruing to clinical trials for the federal award during that quarter.

Categories

Subrecipient Monitoring

Other Findings in this Audit

  • 972144 2023-001
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.800 Organized Approaches to Increase Colorectal Cancer Screening $1.23M
93.399 Cancer Control $537,276